Oropharyngeal Cancer Clinical Trials

96 clinical trials for Oropharyngeal Cancer across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer — RECRUITING · PHASE2
• SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer — RECRUITING · PHASE3
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery — RECRUITING · PHASE1
• A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer — RECRUITING · PHASE2
• Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) — RECRUITING · PHASE2
• Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring — RECRUITING
• Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) — RECRUITING
• Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer — RECRUITING · PHASE2
• A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze) — RECRUITING · PHASE2
• Liposomal Bupivacaine and Transoral Robotic Surgery — RECRUITING
• PIRATES: Image-guided Hyper-fractioned Dose-escalation With Proton Therapy for Head and Neck Cancer — RECRUITING · PHASE1
• Lymphatic Mapping Of Oropharyngeal Cancer — RECRUITING · NA
• Immune Biomarker Study for Head and Neck Cancer — RECRUITING
• Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy — RECRUITING · PHASE3
• A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) — NOT_YET_RECRUITING · PHASE2
• TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck — COMPLETED · NA
• Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies — COMPLETED · PHASE1
• A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer — TERMINATED · PHASE3
• HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients — WITHDRAWN · PHASE2
• CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis. — COMPLETED · PHASE2
• Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx) — COMPLETED
• Depression and Adherence in Head and Neck Cancer — ACTIVE_NOT_RECRUITING
• Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial — ACTIVE_NOT_RECRUITING · NA
• Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers — COMPLETED · NA
• De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma — NOT_YET_RECRUITING · PHASE3
• EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers — ACTIVE_NOT_RECRUITING
• Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer — ACTIVE_NOT_RECRUITING · NA
• Speech-based AI-driven Diagnostics and Rehabilitation for Oral and Oropharyngeal Cancer. — COMPLETED
• HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer — COMPLETED · PHASE1
• Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) — ACTIVE_NOT_RECRUITING
• Men and Women Offering Understanding of Throat HPV — ACTIVE_NOT_RECRUITING
• Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma — ACTIVE_NOT_RECRUITING · NA
• Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma — COMPLETED
• Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma — COMPLETED · PHASE2
• PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing — WITHDRAWN · PHASE2
• HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor — OTHER · PHASE1
• Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers — NOT_YET_RECRUITING · PHASE1
• PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC — OTHER · PHASE2
• Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain — OTHER · NA
• Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer — OTHER · PHASE4
• CytID Analysis of Oral Lesions — TERMINATED
• M7824 in Subjects With HPV Associated Malignancies — COMPLETED · PHASE2
• Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS — COMPLETED · PHASE3

Refine this search